Surgical Option

Science News ◽  
2002 ◽  
Vol 161 (21) ◽  
pp. 323
Author(s):  
Nathan Seppa
Keyword(s):  
Surgical Option

Dynamic cardiomyoplasty as a blomechanical support in end-stage chronic heart failure: a debated surgical option

1994 ◽  
Vol 8 (3) ◽  
pp. 94 ◽  
Author(s):  
R. Lorusso ◽  
G. La Canna ◽  
M. Metra ◽  
M. Zogno ◽  
R. Giubini ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
End Stage ◽  
Surgical Option ◽  
Dynamic Cardiomyoplasty

208 SURGICAL OPTION FOR URETHRAL RECONSTRUCTION: AN AUTOLOGOUS TISSUE-ENGINEERED TUBULAR GRAFT

2011 ◽  
Vol 185 (4S) ◽  
Author(s):  
Annie Imbeault ◽  
Geneviève Bernard ◽  
Gabrielle Ouellet ◽  
Sara Bouhout ◽  
Valérie Cattan ◽  
...  
Keyword(s):  
Urethral Reconstruction ◽  
Autologous Tissue ◽  
Surgical Option

The failing Fontan with atrial flutter: a successful surgical option

1999 ◽  
Vol 68 (5) ◽  
pp. 1845-1848 ◽  
Author(s):  
Fumikazu Nomura ◽  
Kirsten Finucane ◽  
Warren Smith ◽  
Alan R Kerr
Keyword(s):  
Atrial Flutter ◽  
Failing Fontan ◽  
Surgical Option

Transoral thyroidectomy: a viable surgical option with unprecedented complications—a case series

2017 ◽  
Vol 41 (7) ◽  
pp. 809-813 ◽  
Author(s):  
S. Bakkar ◽  
M. Al Hyari ◽  
M. Naghawi ◽  
C. Corsini ◽  
P. Miccoli
Keyword(s):  
Case Series ◽  
Transoral Thyroidectomy ◽  
Surgical Option

scholarly journals New surgical option for optic nerve sheath meningiomas: fully endoscopic transnasal approach

2018 ◽  
Vol 53 (4) ◽  
pp. e142-e144 ◽  
Author(s):  
Cesare Zoia ◽  
Daniele Bongetta ◽  
Fabio Pagella ◽  
Elena R. Antoniazzi ◽  
Paolo Gaetani
Keyword(s):  
Optic Nerve ◽  
Optic Nerve Sheath ◽  
Transnasal Approach ◽  
Nerve Sheath ◽  
Endoscopic Transnasal Approach ◽  
Surgical Option

Outcome of Stretta in a Tertiary Medical Center: A Safe and Effective Non-Surgical Option for Refractory GERD

2021 ◽  
Vol 03 (04) ◽  
Author(s):  
Koldhekar A ◽  
Calderon L ◽  
XieM ◽  
Cai Q
Keyword(s):  
Medical Center ◽  
Refractory Gerd ◽  
Surgical Option

Isolated femoral artery revascularisation with or without iliac inflow improvement – a less invasive surgical option in critical limb ischemia

VASA ◽  
2021 ◽  
pp. 1-7
Author(s):  
Andreas S. Peters ◽  
Katrin Meisenbacher ◽  
Dorothea Weber ◽  
Theodosios Bisdas ◽  
Giovanni Torsello ◽  
...  
Keyword(s):  
Risk Factors ◽  
Femoral Artery ◽  
Critical Limb Ischemia ◽  
Negative Impact ◽  
Limb Ischemia ◽  
Major Amputation ◽  
Lesion Length ◽  
Vascular Intervention ◽  
Selection Of Variables ◽  
Surgical Option

Summary: Background: Isolated femoral artery revascularisation (iFAR) represents a well-established surgical method in the treatment of peripheral arterial disease (PAD) involving common femoral artery disease. Data for iFAR in multilevel PAD are inconsistent, particularly in patients with critical limb ischemia (CLI). The aim of the study was to evaluate the outcome of iFAR in CLI regarding major amputation and reintervention and to identify associated risk factors for this outcome. Patients and methods: The data used have been derived from the German Registry of Firstline Treatment in Critical Limb Ischemia (CRITISCH). A total of 1200 patients were enrolled in 27 vascular centres. This sub-analysis included patients, which were treated with iFAR with/without concomitant iliac intervention. For detection of risk factors for the combined endpoint of major amputation and/or reintervention, selection of variables for multiple regression was conducted using stepwise forward/backward selection by Akaike’s information criterion. Results: 95 patients were included (mean age: 72 years ± 10.82; 64.2% male). Of those, 32 (33.7%) participants reached the combined endpoint. Risk factor analysis revealed continued tobacco use (odds ratio [OR] 2.316, confidence interval [CI] 0.832–6.674), TASC D-lesion (OR: 2.293, CI: 0.869–6.261) and previous vascular intervention in the trial leg (OR: 2.720, CI: 1.037–7.381) to be associated with reaching the combined endpoint. Conclusions: iFAR provides a reasonable, surgical option to treat CLI. Lesion length (TASC D) seems to have a negative impact on outcome. Further research is required to better define the future role of iFAR for combined femoro-popliteal lesions in CLI – best in terms of a randomised controlled trial.

Sign in / Sign up

Export Citation Format

Share Document